Discover trends, market shifts, and competitive outlooks for the glycomic therapeutics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What is the Anticipated CAGR of the Glycomic Therapeutics Market, and What Factors Will Drive It?
There has been a swift expansion in the size of the glycomic therapeutics market in the past few years. It is projected to rise from $164.71 billion in 2024 to $190.03 billion in 2025, representing a compound annual growth rate (CAGR) of 15.4%. Factors such as a greater understanding of the importance of glycan, a surge in chronic illnesses, the creation of drugs for uncommon diseases, and partnerships in glycomics research have contributed to the growth experienced in the historic period.
The market for glycomic therapeutics is projected to experience considerable growth in the coming years, ballooning to a size of $361.09 billion in 2029 with a CAGR of 17.4%. This anticipated growth within the forecast period is due to the increased understanding of glycan biology, the application of precision medicine, growing interest in immunotherapy, heightened funding for research into rare diseases, and the emergence of glycan biomarkers. Key trends set to shape the forecast period include the wider use of glycomic applications within oncology, glycoengineering to enhance therapeutic proteins, the integration of glycomics in immuno-oncology, glycomics applied to rare and genetic disorders, and regulatory considerations pertaining to glycomic drugs.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11894&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Glycomic Therapeutics Market?
The escalation in the number of diabetes cases is predicted to influence the expansion of the glycomic therapeutics market positively. Diabetes, a persistent health issue, impacts the body’s capacity to manage blood sugar (glucose) levels. Changes in glycans, witnessed in diabetes, may result in insulin resistance and other metabolic disorders. Unique glycan patterns are utilized as diabetes biomarkers, aiding in diagnosis, forecasting its advancement, and tracking the reaction to treatments. For instance, the IDF Diabetes Atlas, a Belgium-based worldwide resource that offers comprehensive information and insights into diabetes prevalence, stated in March 2022 that there is a projected rise in global diabetes from 643 million in 2030 to 783 million by 2045, an additional 140 million cases. Consequently, the glycomic therapeutics market’s expansion is supported by the escalating prevalence of diabetes.
Which Key Market Segments Comprise the Glycomic Therapeutics Market and Drive Its Revenue Growth?
The glycomic therapeutics market covered in this report is segmented –
1) By Class: Isolated, Synthetic
2) By Structures: Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans, Targeting Glycosphingolipids, Other Structures
3) By Mode Of Action: Inhibits Neuraminidase, Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate, Erythropoietin And Enzyme Replacement Therapy (ERT), Tissue Plasminogen Activator, Inhibits Glucosylceramide Synthase, Interleukin 1, 2 And 3, Beta And Gamma Interferons, Other Mode Of Action
4) By Indications: Thrombosis And Chemoprophylaxis, Anemia, Anti-Adhesive And Anti-Inflammatory, Cataracts, Gaucher’s Disease, Mps-1 And IV, Cancer, Alzheimer’s Disease, Influenza Type A And B, Other Indications
Subsegments:
1) By Isolated: Natural Glycans, Glycan Derivatives, Glycoproteins
2) By Synthetic: Chemically Synthesized Glycans, Recombinant Glycans, Glycopeptides
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=11894&type=smp
Which Areas Are Leading Regions in the Glycomic Therapeutics Market Expansion Across the Globe?
North America was the largest region in the glycomic therapeutics in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomic therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Strategic Trends Steering theGlycomic Therapeutics Market Direction?
One of the growing trends in the glycomic therapeutics field is product innovation. Many prominent firms in this sector are concentrating on creating innovative and technologically advanced solutions to fortify their market standing. Case in point, Glenmark Pharmaceuticals Limited, a pharmaceutical corporation based in India, is exploring cutting-edge therapies. In April 2022, it introduced a unique fixed-dose combination (FDC) of a DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor), Teneligliptin, and Pioglitazone. This combination aims to enhance glycemic control and minimize insulin resistance in patients suffering from type 2 diabetes.
View the full report here:
https://www.thebusinessresearchcompany.com/report/glycomic-therapeutics-global-market-report
How Is the Glycomic Therapeutics Market Conceptually Defined?
Glycomic therapeutics refers to the development of glycomics-based approaches in the field of therapeutics. Glycome is the complete set of glycans in a cell or organism, which is important for unraveling the complexity of biological systems and their implications for health and disease. Glycan plays important roles in various biological processes, including cell signaling, immune response, and disease development.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11894
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
